EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Next-generation probiotics: the upcoming biotherapeutics

Omnia Momtaz Al-Fakhrany, Engy Elekhnawy

Molecular Biology Reports · 2024-12 · 51 (1)

DOI: 10.1007/s11033-024-09398-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 15.04.2024. Verfasst von Omnia Momtaz Al-Fakhrany und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt. omina.elfakharany@pharm.tanta.edu.eg. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Probiotics. Die Arbeit wurde bisher 193-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tanta University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent and continuing advances in gut microbiome research have pointed out the role of the gut microbiota as an unexplored source of potentially beneficial probiotic microbes. Along the lines of these advances, both public awareness and acceptance of probiotics are increasing. That’s why; academic and industrial research is dedicated to identifying and investigating new microbial strains for the development of next-generation probiotics (NGPs). At this time, there is a growing interest in NGPs as biotherapeutics that alter the gut microbiome and affect various diseases development. In this work, we have focused on some emergent and promising NGPs, specifically Eubacterium hallii, Faecalibacterium prausnitzii, Roseburia spp., Akkermansia muciniphila , and Bacteroides fragilis , as their presence in the gut can have an impact on the development of various diseases. Emerging studies point out the beneficial roles of these NGPs and open up novel promising therapeutic options. Interestingly, these NGPs were found to enhance gastrointestinal immunity, enhance immunotherapy efficacy in cancer patients, retain the intestinal barrier integrity, generate valuable metabolites, especially short-chain fatty acids, and decrease complications of chemotherapy and radiotherapy. Although many of these NGPs are considered promising for the prevention and treatment of several chronic diseases, research on humans is still lacking. Therefore, approval of these microbes from regulatory agencies is rare. Besides, some issues limit their wide use in the market, such as suitable methods for the culture and storage of these oxygen-sensitive microbes. The present review goes over the main points related to NGPs and gives a viewpoint on the key issues that still hinder their wide application. Furthermore, we have focused on the advancement in NGPs and human healthiness investigations by clarifying the limitations of traditional probiotic microorganisms, discussing the characteristics of emerging NGPs and defining their role in the management of certain ailments. Future research should emphasize the isolation, mechanisms of action of these probiotics, safety, and clinical efficacy in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeProbioticsHumansImmunotherapyOxygen

Stichwörter der Autor:innen

Akkermansia muciniphilaB. FragilisFaecalibacterium prausnitziiRoseburia spp.Anti-inflammatory.Immunomodulation

Substanzen

Oxygen

Autor:innen und Institutionen

  • Pharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt. omina.elfakharany@pharm.tanta.edu.eg.
  • Pharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt. engy.ali@pharm.tanta.edu.eg.

Förderung

  • Tanta University

Zitieren

APA

Al-Fakhrany, O. M., & Elekhnawy, E. (2024). Next-generation probiotics: the upcoming biotherapeutics. Molecular Biology Reports, 51(1). https://doi.org/10.1007/s11033-024-09398-5

Vancouver

Al-Fakhrany OM, Elekhnawy E. Next-generation probiotics: the upcoming biotherapeutics. Molecular Biology Reports. 2024;51(1). doi:10.1007/s11033-024-09398-5

BibTeX
@article{AlFakhrany2024,
  author = {Al-Fakhrany, Omnia Momtaz and Elekhnawy, Engy},
  title = {Next-generation probiotics: the upcoming biotherapeutics},
  journal = {Molecular Biology Reports},
  year = {2024},
  volume = {51},
  number = {1},
  doi = {10.1007/s11033-024-09398-5}
}
Kostenlos starten →